Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-02.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 82

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 83
Effect of GnRH analogue on predicted adult height in girls with early puberty

Korean Journal of Pediatrics 2006;49(5):552-557.
Published online May 15, 2006.
Effect of GnRH analogue on predicted adult height in girls with early puberty
Byung-Hoon Ahn, Heon-Seok Han
Department of Pediatrics, College of Medicine and Medical Research Institute, Chungbuk National Univ
조기사춘기 여아에서 성선자극호르몬 방출호르몬 효능약제가 예측성인신장에 미치는 효과
안병훈, 한헌석
충북대학교 의과대학 소아과학교실
Heon-Seok Han, Email: hshan@chungbuk.ac.kr
: The recent results observed in precocious puberty and the hope that interrupting puberty might increase adult height have led to an attempt to use GnRH agonist(GnRHa) in children with premature puberty and a poor growth prognosis. We aimed to analyze the growth promoting effect of GnRHa in girls with early puberty and low predicted adult height(PAH).
: Thirty six girls were recruited. They were grouped according to the GnRHa treatment period(group 1>6 mo, n=18; group 2<6 mo, n=18). The following variables were analyzed before and after GnRHa treatment : chronological age(CA), bone age(BA), ∆age(CA-BA), height, target height (TH), PAH, serum IGF-1, IGFBP-3.
: Duration of the GnRHa treatment was 0.89¡¾0.81 yr(1.37¡¾0.92 yr in group 1, and 0.41¡¾0.08 yr in group 2). Before treatment, none of the variables were different between the two groups. There were no differences in the following variables the between two groups at the end of treatment : CA, BA, ∆age, PAH, serum IGF-1, IGFBP-3. But, growth velocity(GV) and PAH increment during treatment were significantly reduced in group 1. Compared with initial PAH, PAH at the end of treatment was significantly increased(3.7¡¾3.2 cm). The last serum levels of IGF-1 and IGFBP-3 were lower than those before treatment.
: Even though last PAH didn't approach TH, short term GnRHa administration in early puberty with low predicted PAH was somewhat effective. But, GnRHa administration suppressed the growth hormone-IGF-1 axis. Therefore, it is recommended that growth hormone(GH) should be used in combination with GnRHa.
Key Words: Gonadotropin releasing hormone analogue , Early puberty , Growth hormone , Precocious puberty , Bone age , Predicted adult height

METRICS Graph View
  • 2,788 View
  • 19 Download